James Wilson, MD
Physical Medicine & Rehabilitation · Augusta, MENPI 1922234970
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by AbbVie at 22.6% of the total. Reporting peaked in 2024 at $67 and has fallen 67.6% since, to $22 in 2025.
Across 11 payments — averaging $21.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$52
- Boston Scientific$48
- SPR Therapeutics, Inc$43
- GRT US Holding, Inc.$28
- Dentsply IH AB$24
- Avanos Medical$20
- plus $17 from 1 others
What the payments were for
- Food & beverage$231100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 3 | $52 |
| Boston Scientific | 2 | $48 |
| SPR Therapeutics, Inc | 2 | $43 |
| GRT US Holding, Inc. | 1 | $28 |
| Dentsply IH AB | 1 | $24 |
| Avanos Medical | 1 | $20 |
| Medtronic | 1 | $17 |
How this compares
$231 in reported general payments places this provider in the 65th percentile of 34 physical medicine & rehabilitation providers in Maine.
See all physical medicine & rehabilitation providers in Maine →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 242 | $217,344 |
| OxycontinOxycodone Hcl | 230 | $103,093 |
| Buprenorphine | 238 | $67,988 |
| Xtampza ErOxycodone Myristate | 82 | $43,517 |
| Oxymorphone Hcl ErOxymorphone Hcl | 44 | $27,193 |
| Fentanyl | 239 | $23,630 |
| Morphine Sulfate ErMorphine Sulfate | 400 | $10,692 |
| Oxycodone Hcl | 592 | $10,232 |
| Celecoxib | 139 | $9,374 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 151 | $8,893 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 207 | $6,829 |
| Pregabalin | 132 | $6,430 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 26 | $5,030 |
| Hysingla ErHydrocodone Bitartrate | 12 | $4,867 |
| Methadone Hcl | 199 | $3,781 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Augusta
- Robbie VerikerAugusta$986
- Brandi WisemanAugusta$36
- Alycia ReppelLewiston$2K
- Elizabeth LinYarmouth$2K
- Benjamin BranchScarborough$2K
- Cole CarterOrono$1K
- Sadvi GaneshBangor$828
- David GastAuburn$334
- Genevieve HallWaterville$317
- Kathleen RuteckiScarborough$315
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.